Abbreviations: BMI = body mass index; BSA = body surface area; DOXO = cumulative doxorubicin dose; F = female; HSCT = hematopoietic stem cell transplantation; hs-CRP = high-sensitivity C-reactive protein; M = male; proBNP = N-terminal pro-B-type natriuretic peptide; 24hHR = 24-hr mean heart rate; 24hSYS/DIA% = 24-hr mean systolic or diastolic blood pressure. Results are reported as mean ± s.d.
Cardiovascular disease, especially heart failure, has emerged as a leading cause of mortality and morbidity in long-term survivors of childhood cancer. 1 An incidence of asymptomatic myocardial dysfunction ranging from 18 to 57% has been described, and 5% of the survivors develop overt heart failure. 2, 3 The risk of heart failure has a strong dose-dependent association with anthracycline chemotherapy and this risk is further increased in those who have been exposed to chest irradiation, including TBI, and by lifestyle cardiovascular risk factors such as hypertension, smoking, obesity, diabetes and dyslipidemia. 3, 4 Accordingly, international guidelines for cardiovascular surveillance for childhood cancer survivors recommend early monitoring of disease progression with prevention and treatment strategies implemented in the asymptomatic phase. 5 Echocardiography-ideally, three dimensional (3DE)-is able to detect asymptomatic cardiac dysfunction in the early phase of disease. 6 Increased left ventricular mass (LVM) predicts cardiovascular morbidity in childhood cancer survivors. 7 We have shown in our previous study that adolescent and adult survivors of high-risk neuroblastoma (HR NBL) display arterial intima thickening and plaque formation consistent with premature arterial aging. 8 A history of intensive treatment modalities including autologous hematopoietic stem cell transplantation (SCT) was related with these changes. 8 The aim of the present study was to investigate the prevalence of asymptomatic cardiac dysfunction and increased LVM in conjunction with a comprehensive cardiovascular risk assessment in this same cohort of very long-term survivors of HR NBL.
A national cohort of adult and adolescent long-term survivors of childhood HR NBL was enrolled in this follow-up study. Definition of HR NBL was based on the International Neuroblastoma Staging System (INSS) classification system. 9 All patients with 410 years follow-up time were included. The patients were born in 1996 or earlier and were treated at any of the five University Hospitals in Finland between 1980 and 2000. One patient with high-risk retinoblastoma was treated in accordance with our HR NBL protocol, and was therefore included in the study. A total of 24 long-term survivors were identified and 20 (83%) of them were consented. One of the consented patients died before initiation of the study due to complications after lung transplantation. Nineteen (79%) patients were included in the final data analysis. Twenty healthy individually age-and sex-matched controls without chronic or malignant diseases were recruited among medical students and teenage children of hospital employees. HR NBL was diagnosed at a mean age of 1.9 ± 1.1 years (0.2-3.9). Conventional chemotherapy was given as described earlier and included low (o 100 mg/m 2 ) or moderate anthracycline doses (100-250 mg/m 2 ). 5, 8, 9 All patients were consolidated with highdose therapy (HDTx) and autologous SCT (Supplementary Information) at mean time of 0.6 ± 0.3 years (0.3-1.2) from diagnosis. The mean age at the first HDTx was 2.5 ± 1.0 years (1.0-4.7) and the mean follow-up time was 20.1 ± 4.8 years (13.2-27.4). TBI-based HDTx (10-12 Gy) was given to 10 of the 19 survivors and 9 received non-TBI-based HDTx at a mean age of 2.0 ± 0.6 versus 3.1 ± 1.0 years (P = 0.018). Patients with bone metastases, MYCN amplification and poor treatment responses were stratified into TBI-based HDTx as previously described. 9 After recovery, local radiotherapy was administered to the primary and bulky metastatic sites to all but one of the survivors as described (Supplementary Information). 9 Twenty-four-hour ambulatory blood pressure measurement (ABPM) was performed with an automated monitor (Schiller BR-102 Plus, Schiller AG, Baar, Switzerland) in accordance with European recommendations. 8 Blood samples were collected following overnight fasting for a minimum of 11 h. Transthoracic echocardiography (3DE) and tissue Doppler imaging (TDI) were performed (by OTH) from standard views in accordance with the American Society of Echocardiography and the European Association of Cardiovascular Imaging Expert Consensus.
6,10 Muscular endurance, strength and speed were investigated by physical performance tests (Supplementary Information).
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Clinical characteristics and the cardiovascular risk profiles of the survivors and controls are described in Table 1 . Left ventricle indexed mass (LVMI) and volumes were assessed by 3DE and function by 3DE and TDI (Table 2) . LVMI was significantly higher in the survivor group than in the control group. The difference in LVMI was even more profound when indexed for end systolic volume (ESV). LV hypertrophy was found in three survivors (15.8%) using the control group LVMI (42 s.d.) as a reference. LVMI correlated positively with 24 h systolic blood pressure (24 hSYS; r = 0.465, P = 0.003) and with serum triglycerides (r = 0.444, P = 0.005) and negatively with LV systolic (S′, r = − 0.335, P = 0.037) and diastolic (E/E′, r = 0.440, P = 0.005) function. 24 hSYS and being a HR NBL survivor were shown to be predictors of the increased LVMI in simple regression analyses but showed no independent predictive effect when they were entered in multiple linear regression analyses (Supplementary Information). End diastolic volume (EDV) was significantly decreased in the subgroup of survivors who had received TBI when compared with non-TBI ( Table 2 ). The TBI survivors had the lowest systolic and diastolic functional measurements. The cumulative doxorubicin dose was significantly higher in the TBI vs non-TBI survivors ( Table 1 ). The cumulative doxorubicin did not correlate with LV mass or function parameters.
The HR NBL survivors displayed poor physical performance. The performance score was significantly lower compared with the controls in all individual muscle tests, except the leg-lift test (P = 0.058) resulting in a significantly decreased muscle sum score when compared with the controls (Supplementary Information). The muscle sum score correlated inversely with LV volume, mass and function measures (LVMI r = − 0.408, P = 0.010; LVMI/ESV r = − 0.467, P = 0.003; and E/E′ r = − 0.553, Po 0.001).
In the present study, 58% of the survivors received moderate anthracycline doses (100-250 mg/m 2 ) and 42% low-risk doses (o 100 mg/m 2 ). 5 The use of anthracyclines is known to be a primary contributor to cardiotoxicity resulting from direct cardiac myocyte apoptosis and leading to decreased contractility long term. An increased afterload and wall stress may further contribute to the development of LV dysfunction. 12 Survivors, treated with a combination of anthracyclines and chest irradiation, are at high risk of developing congestive heart failure. To date, there is, however, little evidence showing an increased risk of heart failure in children treated with chest irradiation including TBI with doses o15 Gy. 5 In the present study, the most remarkable changes in cardiac function were observed among the survivors treated with TBI (⩽12 Gy) and a moderate dose of anthracyclines ( Table 1) . The irradiated patients also had smaller EDV, increased LVM and increased E/E′ suggesting restrictive physiology. In accordance with present findings, radiation-induced cardiotoxicity is known to be associated more closely with diastolic dysfunction than systolic dysfunction. 13 Myocardial fibrosis may also cause conduction delay, arrhythmias and autonomic dysfunction. 14 Increased heart rate and N-terminal pro-B-type natriuretic peptide (pro-BNP) levels among the survivors further support the presence of cardiac dysfunction. Serum pro-BNPs are released Abbreviations: E = mitral peak velocity of early diastole; E′ = early diastolic peak mitral annular velocity; EF = ejection fraction; EDV = end diastolic volume; ESV = end systolic volume; LVMI = left ventricular mass index; PWD = pulsed wave Doppler; S′ = peak myocardial sustained systolic velocity; TDI = tissue Doppler imaging; 3DE = three-dimensional echocardiography; 6/12/16SDI = 6/12/16 segments systolic dyssynchrony index. Results are reported as mean ± s.d.
in response to myocardial wall stress, and have become one of the established biomarkers for the diagnosis of symptomatic heart failure. 15 An increased heart rate, on the other hand, is known to be an independent risk factor for sudden death in adults. 16 An increased heart rate has previously been identified as an indicator of autonomic dysfunction, which may be myocardial fibrosis related.
14 A decrease in cardiac function was further associated with poor physical performance.
In the general population, classical cardiovascular risk factors are known to contribute to the development of increased LVM related heart failure. 4, 5 In cancer survivors, hypertension is known to increase the risk for cardiac failure independently. 13 In the present study, the survivors had higher triglycerides, higher cholesterol, higher incidence of smoking, blood pressure (BP) and poor physical performance than their healthy controls. Most of these conditions, including high BP, are known to increase when survivors enter middle age. 1 Early detection, appropriate counseling and treatment of cardiovascular risk factors may substantially reduce the risk of premature cardiac disease. Furthermore, cardiovascular risk factors should be routinely screened in the follow-up of adolescent and adult survivors of childhood cancer.
Our main finding is that adult and adolescent very long-term survivors of childhood HR NBL treated with autologous SCT present with significantly increased LVM (15.8%) when compared with age-and sex-matched healthy controls. LVM was negatively associated with systolic and diastolic LV function, increase in cardiac biomarkers and physical performance. The increased LVM and decreased EDV together suggest possible myocardial fibrosis-related restriction. Systolic BP was associated with LVM, suggesting a significant role of BP in the development of LV hypertrophy among cancer survivors. Finally, these observations emphasize the importance of determining LV mass in the assessment of cardiac function in the follow-up of these patients. A healthy lifestyle including physical activity should be promoted among all long-term survivors of childhood cancer.
